Analysts Set Axon Enterprise, Inc. (NASDAQ:AXON) Price Target at $460.33

Axon Enterprise, Inc. (NASDAQ:AXON) has received an average rating of “Buy” from the thirteen brokerages that are presently covering the stock, MarketBeat reports. Thirteen research analysts have rated the stock with a buy recommendation. The average 1-year price objective among brokers that have issued a report on the stock in the last year is $488.67.

Several equities analysts have commented on the company. Needham & Company LLC raised their price objective on Axon Enterprise from $525.00 to $600.00 and gave the company a “buy” rating in a research report on Friday, November 8th. Northland Securities lifted their price target on shares of Axon Enterprise from $365.00 to $550.00 and gave the company an “outperform” rating in a research report on Monday, November 11th. The Goldman Sachs Group upped their price objective on shares of Axon Enterprise from $385.00 to $441.00 and gave the stock a “buy” rating in a report on Wednesday, October 23rd. Robert W. Baird raised their target price on shares of Axon Enterprise from $600.00 to $800.00 and gave the company an “outperform” rating in a research note on Friday. Finally, Morgan Stanley raised Axon Enterprise from an “equal weight” rating to an “overweight” rating and boosted their price target for the stock from $500.00 to $700.00 in a research report on Tuesday, December 3rd.

Insiders Place Their Bets

In other news, Director Julie A. Cullivan sold 1,261 shares of the business’s stock in a transaction on Wednesday, December 4th. The shares were sold at an average price of $682.06, for a total value of $860,077.66. Following the transaction, the director now owns 2,392 shares of the company’s stock, valued at approximately $1,631,487.52. The trade was a 34.52 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, CEO Patrick W. Smith sold 47,314 shares of the business’s stock in a transaction on Tuesday, October 1st. The stock was sold at an average price of $400.07, for a total transaction of $18,928,911.98. Following the completion of the sale, the chief executive officer now owns 2,983,802 shares in the company, valued at approximately $1,193,729,666.14. The trade was a 1.56 % decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 129,739 shares of company stock worth $60,108,622 over the last three months. 6.10% of the stock is currently owned by company insiders.

Institutional Investors Weigh In On Axon Enterprise

Several large investors have recently added to or reduced their stakes in AXON. Blue Trust Inc. grew its holdings in Axon Enterprise by 987.5% during the 2nd quarter. Blue Trust Inc. now owns 87 shares of the biotechnology company’s stock valued at $27,000 after purchasing an additional 79 shares during the last quarter. Quent Capital LLC raised its holdings in shares of Axon Enterprise by 1,875.0% in the third quarter. Quent Capital LLC now owns 79 shares of the biotechnology company’s stock worth $32,000 after buying an additional 75 shares during the period. Prestige Wealth Management Group LLC lifted its stake in shares of Axon Enterprise by 115.8% during the 3rd quarter. Prestige Wealth Management Group LLC now owns 82 shares of the biotechnology company’s stock worth $33,000 after acquiring an additional 44 shares during the last quarter. Brooklyn Investment Group bought a new position in Axon Enterprise in the 3rd quarter valued at $41,000. Finally, Asset Dedication LLC bought a new position in Axon Enterprise in the 2nd quarter valued at $47,000. 79.08% of the stock is owned by institutional investors.

Axon Enterprise Stock Performance

NASDAQ:AXON opened at $687.69 on Friday. The company has a quick ratio of 2.63, a current ratio of 2.96 and a debt-to-equity ratio of 0.32. The firm’s fifty day simple moving average is $516.24 and its 200 day simple moving average is $393.77. The stock has a market cap of $52.44 billion, a P/E ratio of 177.70, a price-to-earnings-growth ratio of 15.13 and a beta of 1.01. Axon Enterprise has a twelve month low of $232.78 and a twelve month high of $698.67.

About Axon Enterprise

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.